Adenoviruses as Vectors for the Transfer of Genetic Information and for the Construction of New Type Vaccines

  • T. I. Tikchonenko
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 257)


Members of adenoviral family represent middle-sized viruses composed of a complex protein capsid and a linear double-stranded DNA of molecular weight 20–22 mD or 35–36 kb coding for about 30 virion and virus-specific proteins. The ends of adenoviral genome have inverted terminal repeats 100–200 nucleotide long, each of which contains identical replication origins. These sites represent the cis-acting element indispensable in any virus vector construction. The second cis-element of adenoviral genome absolutely necessary in the capsid type of viral vectors is the package signal located in the left noncodig part of the DNA molecule 200–300 nucleotides long between the terminal repeat and the El cistron (Doerfler, 1983/1984; Ginsberg, 1984).


Foreign Gene Herpes Virus Recombinant Adenovirus Adenoviral Infection Adenovirus Type 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Berencsi G. & Nasz I., 1983, Adenoviruses and human tumors: regulation of eukaryotic chromatin structure, Arch.Geschwulstforsch. 53:239.PubMedGoogle Scholar
  2. Berkner K. L. & Sharp P.A., 1982, Preperation of adenovirus recombinants using plasmid of viral DNA, in “Eukaryotic viral vectors”, Y.Gluzman, ed., Cold Spring Harbor Laboratory, Cold Spring Harbor.Google Scholar
  3. Berkner K. L. & Sharp P. A., 1985, Effect of the tripartite leader on synthesis of a non-viral protein in an adenovirus 5 recombinant, Nucl. Acid Res., 13:841.CrossRefGoogle Scholar
  4. Berkner K. L., Schaffhausen B., Roberts T. M. & Sharp P. A., 1987, Abundant expression of polyomavirus T antigen and dihydrofolate reductase in an adenovirus recombinant, J. Virol., 61:1213.PubMedGoogle Scholar
  5. Bhat B. M. & Wold W.S.M., 1986, Genetic analysis of mRNA synthesis in adenovirus region E3 at different stages of productive infection by RNA-processing mutants, J. Virol., 60:54.PubMedGoogle Scholar
  6. Borelli E., Hen R. & Chambon P., 1984, Adenovirus2 E1A products repress SV40 enhancer induced stimulation of transcription, Nature, 312:608.CrossRefGoogle Scholar
  7. Chinandurai G., 1983, Adenovirus 21p+ locus codes for a 19 kD tumor antigen that plays an essential role in cell transformation, Cell, 33:759.CrossRefGoogle Scholar
  8. Davidson D. & Hassel J. A., 1987, Overproduction of polyomavirus middle T antigen in mammalian cells through the use of an adenovirus vector, J. Virol., 61:1226.PubMedGoogle Scholar
  9. Davis A. R., & Huang P. P., 1987, Oral vaccines, European Patent Application EP 0181117.Google Scholar
  10. Davis A. R., Kostek B., Mason B. B., Hsiao C. L., Morin J., Barton J., Dheer S. K., Zandler G. & Huang P. P., 1986, Expression of hepatitis B surface antigen with a recombinant adenovirus, in “Vaccines 86”, Cold Spring Harbor Laboratory, Cold Spring Harbor.Google Scholar
  11. Davis A. R., Kostek B., Mason B. B., Hsiao C. L.,. Morin J., Dheer S. K. & Huang P. P., 1985, Expression of hepatitis B surface antigen with a recombinant adenovirus, Proc. Nat. Acad. Sci. USA, 82:7560.PubMedCrossRefGoogle Scholar
  12. Doerfler W., ed., 1983/1984, “The molecular biology of adenoviruses”, Curr. Topics Microbiol. and Immunology, v.109, 110, 111, Springer Verlag, W.Berlin.Google Scholar
  13. Dudding B. A., Top F. H., Scott R. M., Russell P. K. & Buescher E. L., 1972, An analysis of hospitalizations for acute respiratory disease in recruits immunized with adenovirus type 4 and type 7 vaccines, Amer. J. Epidimiol., 95:140.Google Scholar
  14. Fucui Y., Saito I., Shiroke K. & Shimojo H., 1984, Isolation of trans-forming-defective replication-nondefective early region 1B mutants of adenovirus 12, J.Virol., 44:154.Google Scholar
  15. Ghosh-Choudhury G. & Graham F. L., 1987, Stable transfer of mouse dihydrofolate reductase gene into a deficient cell line using human adenovirus vector, Bioch. Biophys. Res. Commun., 147:964.CrossRefGoogle Scholar
  16. Ghosh-Choudhury G., Haj-Ahmad Y. & Graham F. L.,1987, Protein IX, a minor component of the human adenovirus capsid, is essential for the packaging of full-length genomes, The EMBO J.,6,:1733.Google Scholar
  17. Ginsberg H. S., ed.“ The adenoviruses”, Plenum Press, New York.Google Scholar
  18. Gluzman Y., Reichl H. & Solnick D., 1982, Helper-free adenovirus type 5 vectors, in “Eukaryotic viral vectors” Y.Gluzman, ed., Cold Spring Harbor Laboratory, Cold Spring Harbor.Google Scholar
  19. Graham F. L., 1984, Transformation by and oncogenecity of human adenoviruses, in “Adenoviruses”, H.S.Ginsberg, ed., Plenum Press, New York.Google Scholar
  20. Graham F. L., Smiley J., Russel W. C, & Nairn R., 1977, Characteristics of a human cell line transformed by DNA from human adenovirus type 5, J. Virol., 36:59.CrossRefGoogle Scholar
  21. Green M. & Mackey J., 1977, Are oncogenic adenoviruses associated with human cancer? Analysis of human tumors for adenovirus transforming gene sequences, Cold Spring Harbor Conferences of Cell Prolifera-tion, v.4:1027.Google Scholar
  22. Green M., Wold W. & Mackey J., 1979, Analysis of human tonsil and cancer DNAs and RNAs for sequences of group C human adenoviruses, Proc. Nat. Acad. Sci. USA, 76:6606.PubMedCrossRefGoogle Scholar
  23. Haj-Ahmad Y. & Graham F. L., 1986, Development of a helper- independent human adenovirus vector and its use in the transfer of the herpes simplex virus thymidine kinase gene, J. Virol., 57:267.PubMedGoogle Scholar
  24. Hay R. T. & McDougall I. M., 1986, Viable viruses with deletions in the left inverted terminal repeat define the adenovirus origin of DNA replication, J. gen. Virol., 67:321.PubMedCrossRefGoogle Scholar
  25. Jones N. & Shenk T., 1987, Isolation of deletion and substitution mutants of adenovirus type 5, Cell, 13:181.CrossRefGoogle Scholar
  26. Jones L., Ristow S., Yilma T. & Moss B., 1986, Accidental human vaccination with vaccinia virus expressing nucleoprotein gene, Nature, 319:543.PubMedCrossRefGoogle Scholar
  27. Jonson D. C., Ghosh-Choudhury G., Smiley J. R., Fallis L & Graham F. L., 1988, Abundant expression of herpes simplex virus glyco-protein gB using an adenovirus vector, Virology, 164:1.CrossRefGoogle Scholar
  28. Ibelgaufts H. 1982, Are human DNA tumor viruses involved in the pathogenesis of human neurogenetic tumors, Neurosurg. Rew., 5:3.CrossRefGoogle Scholar
  29. Karlsson S., Humphries R. K., Gluzman Y. & Nienhuis A. W., 1985, Transfer of genes into hematopoetic cells using recombinant DNA viruses, Proc. Nat. Acad. Sci. USA, 82:158.PubMedCrossRefGoogle Scholar
  30. Katze M. G., Chen Y. T. & Krug R. M., 1981, Nuclear-cytoplasmic transport and VAI RNA-independent translation of influenza viral messenger RNAs in late adenovirus-infected cells, Cell, 37:483.CrossRefGoogle Scholar
  31. Kaufman R. J., 1985, Identification of the component necessary for adenovirus translational control and their utilization in cDNA expression vectors, Proc. Nat. Acad. Sci. USA, 82:689.PubMedCrossRefGoogle Scholar
  32. Klessig D. F., 1984, Adenovirus-SV40 interactions, in “Adenoviruses” H. S. Ginsberg, ed., Plenum Press, New York.Google Scholar
  33. Logan J. & Pilder S., 1985, The use of adenovirus recombinants to study viral gene expression, in “Genetically altered viruses”, B.Fields, M.A.Martins & D.Kamely, eds., Cold Spring Harbor Laboratory, Cold Spring Harbor.Google Scholar
  34. Mackey J., Green M., Wold W. & Rigden P., 1979, Analysis of human cancer DNA sequences for DNA of human adenovi ruses type 4, J. Nat. Cancer Inst. 62:23.PubMedGoogle Scholar
  35. Mackey J. K., Rigden P. & Green M., 1976, Do highly oncogenic group A human adenoviruses cause human cancer? Analysis of human tumors for adenovirus 12 transforming DNA segments, Proc. Nat. Acad. Sci. USA, 73:4657.PubMedCrossRefGoogle Scholar
  36. Mansour S. L., Grodzicker T. & Tjian R., 1985, An adenovirus vector system used to express polyomavirus tumor antigenes, Proc. Nat. Acad. Sci. USA, 82:1359.PubMedCrossRefGoogle Scholar
  37. Meiklejohn G., 1983, Viral respiratory disease at Lowrey Air Force Base in Denver, 1952–1982, J. Infect. Dis., 148:775.PubMedCrossRefGoogle Scholar
  38. Morin J. E.,Lubeck M. D., Barton J. E., Conley A. J. & Davis A, R., 1987, Recombinant adenovirus induces antibody responce to hepatitis B virus surface antigen in hamsters, Proc. Nat. Acad. Sci. USA, 84:4626.PubMedCrossRefGoogle Scholar
  39. Naroditsky B. S., Miroshnichenko O .I., Ponomareva T. I. & Tikchonenko T. I., 1983, Construction of the eukaryotic vector using adenovirus type 1, Mol. Genet. Microbiol., Virology, 12:28 (in Russian).Google Scholar
  40. Naroditsky B. S., Miroshnichenko O .I., Ponomareva T. I. & Tikchonenko T. I., 1986, Expression of hepatitis B virus gene inserted into recombinant adenovirus, Mol. Genet. Microbiol., Virology, 1:42 (in Russian).Google Scholar
  41. Roizman B. & Jenkins F. J., 1985, Genetic engineering of novel genomes of large DNA viruses, Science, 229:1208.PubMedCrossRefGoogle Scholar
  42. Saito I., Qya Y., Yamamoto K., Yuasa T. & Shimojo H., 1985, Construe- tion of nondefective adenovirus type 5 bearing a 2.8-kilobase hepatitis B virus DNA near the right end of its genome, J. Virol., 54:711.PubMedGoogle Scholar
  43. Shenk T. & Williams J., 1984, Genetic analysis of adenoviruses, Curr. Topics Microbiol. and Immunol., 111:1.CrossRefGoogle Scholar
  44. Struk V. I., Tikchonenko T. I. & Sovzova Z. D., 1987, “Infectious viruses and cancerogenesis”, Publ. House “Naukova Dumka”, Kiev (in Russian).Google Scholar
  45. Takafuji E. T., Gaydos J. C., Allan R. G. & Top F. H., 1979, Simultaneous administration of live enteric-coated adenovirus type 4,7 and 21 vaccines: safety and immunochemistry, J. Infect. Dis., 140:48.PubMedCrossRefGoogle Scholar
  46. Tikchonenko T. I., 1985, Construction of eukaryotic vectors, Biotech-nol., 2:24 (in Russian).Google Scholar
  47. Tiollais P., Charney P. & Vias G. N., 1981, Biology of hepatitis B virus, Science, 213:406.PubMedCrossRefGoogle Scholar
  48. Thummel C., Tjian R. & Grodziker T., 1981, Expression of SV40 large T antigen under control of Ad promoter, Cell, 23:825.PubMedCrossRefGoogle Scholar
  49. van der Eb A. J., & Bernards R., 1984, Transformation and oncogenicity by adenoviruses, Curr. Topics Microbiol. and Immunol., 110:23.CrossRefGoogle Scholar
  50. van Doren K., Hanahan D. & Gluzman Y., 1984, Infection of eucaryotic cells by helper independent recombinant adenoviruses: early region 1 is not obligatory for integration of viral DNA, J. Virol., 50:606.PubMedGoogle Scholar
  51. Velcich A. & Ziff E., 1985, Adenovirus E1A proteins repress transcription from SV40 early promoter, Cell, 40:705.PubMedCrossRefGoogle Scholar
  52. Yarnada M., Lewis J. A. & Grodzicker T., 1985, Overproduction of the protein product of a non-selected foreign gene carried by an adenovirus vector, Proc. Nat. Acad. Aci. USA, 82:3567.CrossRefGoogle Scholar
  53. Young C. S., Shenk T. & Ginsberg H. S., 1984/ The genetic system, in “Adenoviruses”, H.S.Ginsberg, ed., Plenum Press, New York.Google Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • T. I. Tikchonenko
    • 1
  1. 1.Institute of Agricultural BiotechnologyAcademy of Agricultural SciencesMoscowUSSR

Personalised recommendations